Selected article for: "cohort study and patient total"
Author: Guerrero-Fernández de Alba, Inmaculada; Orlando, Valentina; Monetti, Valeria M.; Mucherino, Sara; Gimeno-Miguel, Antonio; Vaccaro, Olga; Forjaz, Maria João; Poblador Plou, Beatriz; Prados-Torres, Alexandra; Riccardi, Gabriele; Menditto, Enrica
Title: Comorbidity in an Older Population with Type-2 Diabetes Mellitus: Identification of the Characteristics and Healthcare Utilization of High-Cost Patients
  • Cord-id: mn0cj8v6
  • Document date: 2020_11_30
    • ID: mn0cj8v6
    Snippet: Objectives: Little is known about the specific comorbidities contributing to higher costs in patients with type-2 diabetes mellitus (T2DM), particularly in older cases. We aimed to evaluate the prevalence, type, and cost of comorbidities occurring in older T2DM patients versus older non-T2DM patients, and the factors associated with high cost (HC) T2DM patients. Methods: Retrospective cohort study using information from the Campania Region healthcare database. People aged ≥65 years who receive
    Document: Objectives: Little is known about the specific comorbidities contributing to higher costs in patients with type-2 diabetes mellitus (T2DM), particularly in older cases. We aimed to evaluate the prevalence, type, and cost of comorbidities occurring in older T2DM patients versus older non-T2DM patients, and the factors associated with high cost (HC) T2DM patients. Methods: Retrospective cohort study using information from the Campania Region healthcare database. People aged ≥65 years who received ≥2 prescriptions for antidiabetic drugs were identified as “T2DM patients.” Comorbidities among T2DM and non-T2DM groups were assessed through the RxRiskV Index (modified version). T2DM individuals were classified according to the total cost distribution as HC or “non-high cost.” Two sub-cohorts of HC T2DM patients were assessed: above 90th and 80th percentile of the total cost. Age- and sex-adjusted logistic regression models were created. Results: Among the T2DM cohort, concordant and discordant comorbidities occurred significantly more frequently than in the non-T2DM cohort. Total mean annual cost per T2DM patient due to comorbidities was €7,627 versus €4,401 per non-T2DM patient. Among T2DM patients identified as being above 90th and 80th percentiles of cost distribution, the total annual costs were >€19,577 and >€2,563, respectively. The hospitalization cost was higher for T2DM cases. Strongest predictors of being a HC T2DM patient were having ≥5 comorbidities and renal impairment. Conclusion: HC patients accrued >80% of the total comorbidities cost in older T2DM patients. Integrated care models, with holistic and patient-tailored foci, could achieve more effective T2DM care.

    Search related documents:
    Co phrase search for related documents
    • acute coronary syndrome and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute coronary syndrome and logistic regression model: 1, 2
    • acute coronary syndrome and low prevalence: 1, 2
    • adjusted odd ratio and logistic regression: 1, 2, 3, 4, 5
    • adjusted odd ratio and logistic regression model: 1, 2
    • administrative database and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • administrative database and logistic regression model: 1
    • logistic regression and low prevalence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47
    • logistic regression model and low prevalence: 1, 2, 3, 4, 5, 6, 7, 8